Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 839.18%96.94M | 16.09%-40.45M | 37.27%-13.11M | -44.34%-48.21M | -25.64%-20.91M | -498.87%-33.4M | -158.51%-16.64M | 127.16%8.37M | 271.10%28.44M | -202.15%-30.83M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 57.64%-707K | ---- | -45.64%-1.67M | ---- | 0.00%-1.15M | ---- | 25.73%-1.15M | ---- | -7.90%-1.54M |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | --28K | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | 177.81%38.86M | ---- | 803.10%13.99M | ---- | 117.75%1.55M | ---- | -178.31%-8.73M | ---- | 49.99%11.15M |
| -Impairment of goodwill | ---- | --8.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 117.02%30.36M | ---- | 803.10%13.99M | ---- | 117.75%1.55M | ---- | -178.31%-8.73M | ---- | 49.99%11.15M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---755K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---755K |
| Depreciation and amortization: | ---- | -21.90%7.55M | ---- | 4.11%9.67M | ---- | -14.61%9.29M | ---- | -11.16%10.88M | ---- | -12.59%12.25M |
| -Amortization of intangible assets | ---- | -0.13%774K | ---- | 0.13%775K | ---- | --774K | ---- | ---- | ---- | -87.12%281K |
| Financial expense | ---- | -4.28%5.89M | ---- | 32.12%6.15M | ---- | 923.08%4.66M | ---- | -71.79%455K | ---- | 260.85%1.61M |
| Special items | -183.17%-17.51M | ---- | 199.90%21.05M | -100.18%-1K | 18.96%7.02M | -60.68%569K | 209.04%5.9M | -96.35%1.45M | -114.89%-5.41M | -52.29%39.6M |
| Operating profit before the change of operating capital | 900.47%79.43M | 155.60%11.14M | 157.18%7.94M | -8.43%-20.04M | -29.31%-13.89M | -263.85%-18.48M | -146.63%-10.74M | -64.17%11.28M | 16.76%23.03M | -76.44%31.48M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 722.13%44.43M | -50.61%6.49M | 112.96%5.4M | 187.28%13.14M | 18.91%-41.7M | 95.22%-15.06M | 92.86%-51.42M | -47.03%-314.69M | -4,201.59%-719.75M | -242.47%-214.03M |
| Accounts receivable (increase)decrease | -982.79%-150.06M | 77.83%-7.92M | -30.13%-13.86M | -120.26%-35.74M | -110.22%-10.65M | 353.11%176.44M | 56.34%104.25M | -83.49%38.94M | 2.57%66.68M | -1.77%235.8M |
| Accounts payable increase (decrease) | 481.20%142.8M | 250.66%18.59M | -64.99%24.57M | 82.49%-12.34M | 209.98%70.18M | -50.24%-70.46M | -77,923.17%-63.82M | -300.60%-46.9M | -94.69%82K | 116.41%23.38M |
| Advance payment increase (decrease) | ---- | ---- | ---- | ---- | ---- | -160.44%-55K | ---- | 111.40%91K | ---- | ---798K |
| Special items for working capital changes | -135.02%-3.85M | 215.00%1.99M | ---1.64M | -164.64%-1.73M | ---- | 176.10%2.68M | ---- | 10.15%-3.52M | ---- | -21.58%-3.92M |
| Cash from business operations | 402.94%112.75M | 153.42%30.29M | 467.26%22.42M | -175.54%-56.71M | 118.19%3.95M | 123.85%75.07M | 96.55%-21.72M | -537.75%-314.8M | -706.77%-629.96M | -56.55%71.91M |
| Other taxs | ---164K | ---- | ---- | 129.65%212K | ---- | 84.99%-715K | ---- | 67.69%-4.77M | ---- | 63.52%-14.75M |
| Special items of business | ---- | ---- | ---- | ---- | -112.64%-536K | ---- | 171.45%4.24M | ---- | 64.24%-5.93M | ---- |
| Net cash from operations | 402.20%112.58M | 153.62%30.29M | 556.26%22.42M | -175.99%-56.5M | 119.54%3.42M | 123.27%74.35M | 97.25%-17.48M | -659.02%-319.56M | -829.00%-635.89M | -54.30%57.17M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 30.51%710K | -57.64%707K | -31.14%544K | 45.64%1.67M | 58.00%790K | 0.00%1.15M | -33.33%500K | -25.73%1.15M | 5.63%750K | 7.90%1.54M |
| Loan receivable (increase) decrease | 59.07%-4.29M | -177.91%-13.94M | -619.48%-10.49M | -4,223.28%-5.02M | -3,456.10%-1.46M | 83.75%-116K | 91.91%-41K | -243.09%-714K | -149.56%-507K | 122.90%499K |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | --88K | ---- | ---- | ---- |
| Purchase of fixed assets | ---1.19M | 13.83%-1.25M | ---- | -91.52%-1.45M | -249.84%-1.1M | ---755K | ---313K | ---- | ---- | 54.79%-1.01M |
| Purchase of intangible assets | ---5.53M | ---5M | ---- | ---- | ---- | ---- | ---- | -53.74%-30.88M | ---- | 83.12%-20.09M |
| Sale of subsidiaries | ---174K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.62M |
| Acquisition of subsidiaries | --315K | ---2.49M | ---- | ---- | ---- | --1.4M | --1.4M | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---40K | ---- | ---- | ---- | -89.71%25.28M | ---- | --245.6M |
| Net cash from investment operations | -2.20%-10.17M | -354.47%-21.96M | -464.15%-9.95M | -388.82%-4.83M | -208.03%-1.76M | 132.33%1.67M | 571.60%1.63M | -102.26%-5.17M | -99.85%243K | 287.89%229.17M |
| Net cash before financing | 721.19%102.42M | 113.59%8.33M | 654.51%12.47M | -180.67%-61.33M | 110.43%1.65M | 123.41%76.02M | 97.51%-15.85M | -213.41%-324.74M | -356.83%-635.65M | 9,106.91%286.34M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 1,600.96%93.66M | -3.65%99.3M | -94.16%5.51M | -2.53%103.06M | 9.54%94.36M | --105.73M | --86.14M | ---- | ---- | 120.42%1.47M |
| Refund | -13,503.45%-90.74M | -3.00%-89.8M | 99.12%-667K | -736.52%-87.18M | -31,543.93%-75.63M | -2.43%-10.42M | 97.63%-239K | 49.54%-10.18M | -0.68%-10.07M | -226.97%-20.16M |
| Interest paid - financing | -5.91%-2.74M | 4.28%-5.89M | 25.17%-2.59M | -32.12%-6.15M | -296.00%-3.46M | -923.08%-4.66M | -297.27%-874K | 2.99%-455K | -17.02%-220K | -4.92%-469K |
| Net cash from financing operations | 100.58%3K | -65.83%1.92M | -103.84%-516K | -93.50%5.62M | -83.75%13.43M | 660.43%86.54M | 716.36%82.64M | 42.37%-15.44M | 1.72%-13.41M | -122.11%-26.79M |
| Net Cash | 756.66%102.42M | 118.41%10.25M | -20.74%11.96M | -134.27%-55.7M | -77.41%15.09M | 147.79%162.57M | 110.29%66.78M | -231.07%-340.18M | -377.54%-649.06M | 108.84%259.54M |
| Begining period cash | 2.44%429.76M | -11.72%419.51M | -11.72%419.51M | 52.00%475.21M | 52.00%475.21M | -52.11%312.65M | -52.11%312.65M | 65.99%652.83M | 65.99%652.83M | 46.20%393.29M |
| Items Period | ---- | ---474K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash at the end | 23.34%532.19M | 2.33%429.29M | -12.00%431.47M | -11.72%419.51M | 29.22%490.3M | 52.00%475.21M | 9,956.51%379.43M | -52.11%312.65M | -99.40%3.77M | 65.99%652.83M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 65.99%652.83M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 65.99%652.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Jindao Liancheng Certified Public Accountants Co., Ltd. | -- | Jindao Liancheng Certified Public Accountants Co., Ltd. | -- | Jindao Liancheng Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.